Entry |
|
Symbol |
PRKCG, PKC-gamma, PKCC, PKCG, PKCI(3), PKCgamma, SCA14
|
Name |
(RefSeq) protein kinase C gamma
|
KO |
|
Organism |
|
Pathway |
hsa01521 | EGFR tyrosine kinase inhibitor resistance |
hsa04070 | Phosphatidylinositol signaling system |
hsa04270 | Vascular smooth muscle contraction |
hsa04613 | Neutrophil extracellular trap formation |
hsa04650 | Natural killer cell mediated cytotoxicity |
hsa04666 | Fc gamma R-mediated phagocytosis |
hsa04670 | Leukocyte transendothelial migration |
hsa04723 | Retrograde endocannabinoid signaling |
hsa04750 | Inflammatory mediator regulation of TRP channels |
hsa04919 | Thyroid hormone signaling pathway |
hsa04925 | Aldosterone synthesis and secretion |
hsa04928 | Parathyroid hormone synthesis, secretion and action |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa04960 | Aldosterone-regulated sodium reabsorption |
hsa04961 | Endocrine and other factor-regulated calcium reabsorption |
hsa05022 | Pathways of neurodegeneration - multiple diseases |
hsa05163 | Human cytomegalovirus infection |
hsa05170 | Human immunodeficiency virus 1 infection |
hsa05207 | Chemical carcinogenesis - receptor activation |
|
Network |
|
Element |
N00023 | EGF-EGFR-PLCG-ERK signaling pathway |
N00024 | Mutation-activated EGFR to PLCG-ERK signaling pathway |
N00025 | EML4-ALK fusion kinase to PLCG-ERK signaling pathway |
N00227 | TGFA-EGFR-PLCG-PKC signaling pathway |
N00228 | TGFA-overexpression to PLCG-PKC signaling pathway |
N00413 | CXCR4-GNB/G-PLCB-PKC signaling pathway |
N00414 | HCMV US27 to CXCR4-GNB/G-PLCB-PKC signaling pathway |
N00428 | CCR5-GNB/G-PLCB/G-PKC signaling pathway |
N00546 | CXCL12-CXCR4-PKC-ERK signaling pathaway |
N00547 | HBV LHBs to PKC-ERK signaling pathway |
N00793 | TSH-DUOX2-TG signaling pathway |
N00869 | KISS1-KISS1R-PLCB-PKC signaling pathway |
N00873 | GnRH-GnRHR-PLCB-PKC signaling pathway |
N00882 | TAC3-TACR3-PLC-PKC signaling pathway |
N00918 | TRH-TRHR-PLCB-PKC signaling pathway |
N00953 | mGluR1-TRPC3 signaling pathway |
N00955 | Mutation-inactivated PRKCG to mGluR1-TRPC3 signaling pathway |
N00956 | Mutation-activated PRKCG to mGluR1-TRPC3 signaling pathway |
N01741 | Ca2+/TRPC3 signaling pathway |
|
Disease |
H00063 | Spinocerebellar ataxia (SCA) |
|
Drug target |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
5582 (PRKCG)
04012 ErbB signaling pathway
5582 (PRKCG)
04014 Ras signaling pathway
5582 (PRKCG)
04015 Rap1 signaling pathway
5582 (PRKCG)
04310 Wnt signaling pathway
5582 (PRKCG)
04370 VEGF signaling pathway
5582 (PRKCG)
04066 HIF-1 signaling pathway
5582 (PRKCG)
04020 Calcium signaling pathway
5582 (PRKCG)
04070 Phosphatidylinositol signaling system
5582 (PRKCG)
04071 Sphingolipid signaling pathway
5582 (PRKCG)
04150 mTOR signaling pathway
5582 (PRKCG)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04510 Focal adhesion
5582 (PRKCG)
04540 Gap junction
5582 (PRKCG)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
5582 (PRKCG)
04650 Natural killer cell mediated cytotoxicity
5582 (PRKCG)
04666 Fc gamma R-mediated phagocytosis
5582 (PRKCG)
04670 Leukocyte transendothelial migration
5582 (PRKCG)
09152 Endocrine system
04911 Insulin secretion
5582 (PRKCG)
04929 GnRH secretion
5582 (PRKCG)
04921 Oxytocin signaling pathway
5582 (PRKCG)
04935 Growth hormone synthesis, secretion and action
5582 (PRKCG)
04918 Thyroid hormone synthesis
5582 (PRKCG)
04919 Thyroid hormone signaling pathway
5582 (PRKCG)
04928 Parathyroid hormone synthesis, secretion and action
5582 (PRKCG)
04916 Melanogenesis
5582 (PRKCG)
04925 Aldosterone synthesis and secretion
5582 (PRKCG)
09153 Circulatory system
04270 Vascular smooth muscle contraction
5582 (PRKCG)
09154 Digestive system
04970 Salivary secretion
5582 (PRKCG)
04971 Gastric acid secretion
5582 (PRKCG)
04972 Pancreatic secretion
5582 (PRKCG)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
5582 (PRKCG)
04961 Endocrine and other factor-regulated calcium reabsorption
5582 (PRKCG)
09156 Nervous system
04724 Glutamatergic synapse
5582 (PRKCG)
04727 GABAergic synapse
5582 (PRKCG)
04725 Cholinergic synapse
5582 (PRKCG)
04728 Dopaminergic synapse
5582 (PRKCG)
04726 Serotonergic synapse
5582 (PRKCG)
04720 Long-term potentiation
5582 (PRKCG)
04730 Long-term depression
5582 (PRKCG)
04723 Retrograde endocannabinoid signaling
5582 (PRKCG)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
5582 (PRKCG)
09159 Environmental adaptation
04713 Circadian entrainment
5582 (PRKCG)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
5582 (PRKCG)
05206 MicroRNAs in cancer
5582 (PRKCG)
05205 Proteoglycans in cancer
5582 (PRKCG)
05207 Chemical carcinogenesis - receptor activation
5582 (PRKCG)
05231 Choline metabolism in cancer
5582 (PRKCG)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
5582 (PRKCG)
05214 Glioma
5582 (PRKCG)
05223 Non-small cell lung cancer
5582 (PRKCG)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
5582 (PRKCG)
05161 Hepatitis B
5582 (PRKCG)
05171 Coronavirus disease - COVID-19
5582 (PRKCG)
05163 Human cytomegalovirus infection
5582 (PRKCG)
09174 Infectious disease: parasitic
05146 Amoebiasis
5582 (PRKCG)
05143 African trypanosomiasis
5582 (PRKCG)
09164 Neurodegenerative disease
05017 Spinocerebellar ataxia
5582 (PRKCG)
05022 Pathways of neurodegeneration - multiple diseases
5582 (PRKCG)
09165 Substance dependence
05031 Amphetamine addiction
5582 (PRKCG)
05032 Morphine addiction
5582 (PRKCG)
09166 Cardiovascular disease
05415 Diabetic cardiomyopathy
5582 (PRKCG)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
5582 (PRKCG)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:hsa01001]
5582 (PRKCG)
Enzymes [BR:hsa01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.13 protein kinase C
5582 (PRKCG)
Protein kinases [BR:hsa01001]
Serine/threonine kinases: AGC group
PKC family [OT]
5582 (PRKCG)
|
SSDB |
|
Motif |
|
Other DBs |
|
Structure |
|
LinkDB |
|
Position |
19:53881094..53907652
|
AA seq |
697 aa
MAGLGPGVGDSEGGPRPLFCRKGALRQKVVHEVKSHKFTARFFKQPTFCSHCTDFIWGIG
KQGLQCQVCSFVVHRRCHEFVTFECPGAGKGPQTDDPRNKHKFRLHSYSSPTFCDHCGSL
LYGLVHQGMKCSCCEMNVHRRCVRSVPSLCGVDHTERRGRLQLEIRAPTADEIHVTVGEA
RNLIPMDPNGLSDPYVKLKLIPDPRNLTKQKTRTVKATLNPVWNETFVFNLKPGDVERRL
SVEVWDWDRTSRNDFMGAMSFGVSELLKAPVDGWYKLLNQEEGEYYNVPVADADNCSLLQ
KFEACNYPLELYERVRMGPSSSPIPSPSPSPTDPKRCFFGASPGRLHISDFSFLMVLGKG
SFGKVMLAERRGSDELYAIKILKKDVIVQDDDVDCTLVEKRVLALGGRGPGGRPHFLTQL
HSTFQTPDRLYFVMEYVTGGDLMYHIQQLGKFKEPHAAFYAAEIAIGLFFLHNQGIIYRD
LKLDNVMLDAEGHIKITDFGMCKENVFPGTTTRTFCGTPDYIAPEIIAYQPYGKSVDWWS
FGVLLYEMLAGQPPFDGEDEEELFQAIMEQTVTYPKSLSREAVAICKGFLTKHPGKRLGS
GPDGEPTIRAHGFFRWIDWERLERLEIPPPFRPRPCGRSGENFDKFFTRAAPALTPPDRL
VLASIDQADFQGFTYVNPDFVHPDARSPTSPVPVPVM |
NT seq |
2094 nt +upstreamnt +downstreamnt
atggctggtctgggccccggcgtaggcgattcagaggggggaccccggcccctgttttgc
agaaagggggccctgaggcagaaggtggtccacgaagtcaagagccacaagttcaccgct
cgcttcttcaagcagcccaccttctgcagccactgcaccgacttcatctggggtatcgga
aagcagggcctgcaatgtcaagtctgcagctttgtggttcatcgacgatgccacgaattt
gtgaccttcgagtgtccaggcgctgggaagggcccccagacggacgacccccggaacaaa
cacaagttccgcctgcatagctacagcagccccaccttctgcgaccactgtggctccctc
ctctacgggcttgtgcaccagggcatgaaatgctcctgctgcgagatgaacgtgcaccgg
cgctgtgtgcgtagcgtgccctccctgtgcggtgtggaccacaccgagcgccgcgggcgc
ctgcagctggagatccgggctcccacagcagatgagatccacgtaactgttggcgaggcc
cgtaacctaattcctatggaccccaatggtctctctgatccctatgtgaaactgaagctc
atcccagaccctcggaacctgacgaaacagaagacccgaacggtgaaagccacgctaaac
cctgtgtggaatgagacctttgtgttcaacctgaagccaggggatgtggagcgccggctc
agcgtggaggtgtgggactgggaccggacctcccgcaacgacttcatgggggccatgtcc
tttggcgtctcggagctgctcaaggcgcccgtggatggctggtacaagttactgaaccag
gaggagggcgagtattacaatgtgccggtggccgatgctgacaactgcagcctcctccag
aagtttgaggcttgtaactaccccctggaattgtatgagcgggtgcggatgggcccctct
tcctctcccatcccctccccttcccctagtcccaccgaccccaagcgctgcttcttcggg
gcgagtccaggacgcctgcacatctccgacttcagcttcctcatggttctaggaaaaggc
agttttgggaaggtgatgctggccgagcgcaggggctctgatgagctctacgccatcaag
atcttgaaaaaggacgtgatcgtccaggacgacgatgtggactgcacgctggtggagaaa
cgtgtgctggcgctggggggccggggtcctggcggccggccccacttcctcacccagctc
cactccaccttccagaccccggaccgcctgtatttcgtgatggagtacgtcaccggggga
gacttgatgtaccacattcaacagctgggcaagtttaaggagccccatgcagcgttctac
gcggcagaaatcgctatcggcctcttcttccttcacaatcagggcatcatctacagggac
ctgaagctggacaatgtgatgctggatgctgagggacacatcaagatcactgactttggc
atgtgtaaggagaacgtcttccccgggacgacaacccgcaccttctgcgggaccccggac
tacatagccccggagatcattgcctaccagccctatgggaagtctgtcgattggtggtcc
tttggagttctgctgtatgagatgttggcaggacagcctcccttcgatggggaggacgag
gaggagctgtttcaggccatcatggaacaaactgtcacctaccccaagtcgctttcccgg
gaagccgtggccatctgcaaggggttcctgaccaagcacccagggaagcgcctgggctca
gggcctgatggggaacctaccatccgtgcacatggctttttccgctggattgactgggag
cggctggaacgattggagatcccgcctcctttcagaccccgcccgtgtggccgcagcggc
gagaactttgacaagttcttcacgcgggcggcgccagcgctgacccctccagaccgccta
gtcctggccagcatcgaccaggccgatttccagggcttcacctacgtgaaccccgacttc
gtgcacccggatgcccgcagccccaccagcccagtgcctgtgcccgtcatgtaa |